Seeking Alpha

VRX
Valeant Pharmaceuticals International, Inc.

5/26/2012, 12:38 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
VRX Market Currents more »
  • May 16 Reasons for selling a stock can be many, but there's only one reason for insiders to buy : they expect the stock to go higher. Looking for a leg-up on where to put some money to work? Here's what a couple insiders have been doing this week: On Monday, Valeant Pharmaceuticals' (VRX) Director, Laurence E. Paul, bought 5k shares of VRX, while on the same day Rosetta Resources (ROSE) Executive VP, CFO & Treasurer John E. Hagale bought 6k worth of of his own company as well.
    2 Comments
    [U.S. Economy, Healthcare, Commodities, Quick Ideas]
VRX in Focus more »
VRX Cramer more »
Currently, there are no Cramer articles on VRX.
VRX Instablog posts more »
  • Glenn Greenberg - Brave Warrior Capital Q4/2011 Fund Portfolio
    Fri, Mar 9 • Dividend Sheet • Comment!
  • Wallace R. Weitz - Weitz Value Q4-2011 Fund Portfolio
    Wed, Feb 15 • Dividend Sheet • Comment!
  • Richard T. Cunniff – Sequoia Q3-2011 Fund Portfolio
    Sun, Jan 8 • Dividend Sheet • Comment!
  • Wallace R. Weitz - Weitz Value Q3-2011 Fund Portfolio
    Sun, Nov 6, 2011 • Dividend Sheet • Comment!
  • Glenn Greenberg - Brave Warrior Capital Q2-2011 Fund Portfolio
    Fri, Aug 19, 2011 • Dividend Sheet • Comment!
Write a post on VRX
VRX StockTalks
VRX vs. ETF Alternatives
Company Description

We are a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products. Our specialty pharmaceutical and OTC products are marketed under brand names and are sold in the United States, Canada, Australia and New Zealand, where we... More

Sector: Healthcare
Industry: Drug Delivery & Accessories
Country: Canada